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ABSTRACT
Introduction: Asymptomatic retinal emboli
have been associated with diabetes, the
presence of significant carotid artery stenosis
(C70%) and an increased risk of stroke.
However, there is no clear guidance on how
best to investigate and manage patients found
to have asymptomatic retinal emboli.
Therefore, this study aimed to assess the
incidence of significant carotid artery stenosis
in patients found to have asymptomatic retinal
emboli at diabetic retinopathy screening, and to
examine disease management approaches
among these patients.
Methods: Patients with new retinal emboli
visible at diabetic retinopathy screening were
referred to a medical retinopathy clinic and
underwent examinations according to a
standardized protocol, including carotid
Doppler ultrasound and echocardiography.
Case notes of patients referred between
January 2013 and April 2014 were reviewed.
Results of investigations, medication changes
and the number of patients who underwent
relevant surgical interventions were noted.
Results: Retinal emboli were present in 44 of
13,643 people screened (0.32%). Full data were
available for 39 patients. Twenty-two patients
(56%) had relevant medication changes. Nine
(23%) patients had significant carotid artery
stenosis. One underwent carotid
endarterectomy, and eight received maximal
medical therapy.
Conclusion: Significant carotid artery stenosis
was not uncommon in patients with incident
retinal emboli at retinal screening. The referral
and investigation protocols identified
individuals at risk of cerebrovascular events
and led to optimized management. Pathways
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utilizing Doppler ultrasound and physician
referral should be more widely implemented.
Keywords: Carotid artery stenosis; Diabetic
retinopathy screening; Diabetes; Retinal emboli
INTRODUCTION
Retinal screening provides an opportunity to not
only identify diabetic retinopathy, but also to
investigate additional retinal pathology such as
retinal emboli,whichhavebeenassociatedwithan
increase inall-causeandstroke-relatedmortality in
the general population [1]. The Beaver Dam Eye
Study showed a higher prevalence of retinal
emboli in patients with diabetes, with a
statistically significant odds ratio of 2.39 [2].
Definitive guidance is lacking regarding the
use of investigations such as carotid Doppler
ultrasound and echocardiography for patients
with asymptomatic retinal emboli [3, 4].
Significant carotid artery stenosis (stenosis
C70%) has been found in individuals with
retinal emboli [3–5], with a reported risk of
stroke of 3.6–13% per year, depending on the
presence or absence of symptoms [6, 7]. In
addition, there are no clear guidelines as to the
optimal management of patients with
asymptomatic retinal emboli found on routine
retinal imaging. The current literature suggests
that this group of patients should undergo an
assessment of cardiovascular risk factors and that
physicians should be involved in the care of
these patients [3, 4]. However, implementation
of this approach appears to be limited.
Therefore, this study aimed to assess the
incidence of significant carotid artery stenosis
among diabetic patients with asymptomatic
retinal emboli found at annual photographic
screening, and to examine the investigations
and disease management carried out as a result.
Such information may help to determine
monitoring and disease management
approaches that are most beneficial in the care
of this group of patients.
METHODS
Referral Pathway
Annual digital retinal photography for all patients
with diabetes was established in the Sunderland
and South Tyneside area in 2002. Images are
graded according to national guidelines based on
the severity of diabetic retinopathy. If a retinal
embolus is identified, the patient is referred to a
specialist physician-led clinic. Patients are
assessed to determine the presence of symptoms
as a result of the retinal embolus or any carotid
bruits, and then under appropriate examinations,
including carotid Doppler ultrasound and
echocardiography in all patients, according to a
defined protocol. If a patient is found to have
stenosis of 70% or greater in one carotid artery, a
multidisciplinary team consisting of vascular
surgeons, radiologists, vascular ultrasound
technicians, and stroke and diabetes physicians
discusses the possibility of surgical intervention,
including carotid endarterectomy or stenting.
Twenty-four hour ambulatory blood pressure
monitoring (24-h ABPM) is obtained if blood
pressure in the clinic is suboptimal.
Study Design
The studywas designed as a retrospective case note
review of patients referred to this service between
January 2013 and April 2014. Data were collected
frommedical notes and hospital e-records using a
pre-designed pro forma, which included risk
factors for cardiovascular disease, cardiovascular
comorbidity, previous cerebrovascular events with
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corresponding Doppler results, baseline blood
pressure (BP), body mass index (BMI), glycated
hemoglobin (HbA1c), lipid profile, 24-h ABPM,
and outcomes after discussion with the
multidisciplinary cardiovascular assessment team.
Results of any relevant imaging studieswerenoted,
as well as changes in medical treatment and
surgical interventions. In order to determine
whether individuals with elevated blood pressure,
HbA1c or total cholesterol received appropriate
medication changes, these parameters were
defined as blood pressure greater than
140/90 mmHg, HbA1c greater than 53 mmol/mol
and total cholesterol greater than 5 mmol/L.
Patients who did not attend the clinic on
three occasions were excluded. The study was
designated as a service review and, as such, did
not require ethical approval. This article does not
contain any new studies with human or animal
subjects performed by any of the authors.
Incidence of Retinal Emboli
To determine the incidence of retinal emboli
among individuals with diabetes in the local
area, all cases identified between January 2013
and March 2014 were used as the numerator.
The number of patients screened during the
study period was used as the denominator.
Statistics
Mean values and standard deviations for
baseline characteristics of the cohort were
calculated using Microsoft Excel software.
RESULTS
Forty-five eyes of 44 patients were identified
from screening images as having new retinal
emboli during the study period, all of whom
had type 2 diabetes. Five patients were excluded
from the study: four failed to attend the clinic,
and one patient died of pneumonia during
follow-up. Therefore, data from 39 patients
were analyzed. A retinal embolus was present
in the right eye in 25 patients and in the left eye
in 14. Three patients had multiple emboli. Two
patients had two emboli in one eye, and
another patient had an embolus in both the
left and right eyes. Further details of the cohort
are given in Table 1.
During the course of the study, 13,643
individuals underwent retinal screening in the
trust, which resulted in an incidence of retinal
emboli in individuals with diabetes in
Sunderland of 0.32% (32 in 10,000). At the
initial clinic appointment, all patients were
confirmed to be asymptomatic, although one
patient experienced an episode of amaurosis
fugax while under medical clinic review. During
the study period, there were no separate
referrals from the ophthalmology department
as a result of detecting asymptomatic retinal
emboli in diabetic patients.
Seventy-two percent (28/39) of the patients
were men. Twenty-one percent (8/39) were
current smokers, and 8% (3/39) were
ex-smokers. Ischemic heart disease was present
in 12/39 (31%), with 6/39 (12%) having
previously undergone coronary artery bypass
surgery. Twelve percent had a history of
myocardial infarction, and 6/39 (12%) had
suffered a stroke prior to the detection of the
retinal embolus.
Eight patients (21%) were found to have
significant carotid artery stenosis or complete
occlusion on carotid Doppler ultrasound
(Table 2). Doppler ultrasound was conducted
at a mean of 13 days after the first appointment.
Nine patients underwent carotid angiography
after Doppler ultrasound to confirm the level of
stenosis. Five of the nine angiograms were
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performed at the recommendation of the
cardiovascular assessment team. The other
four angiograms were performed to confirm
complete occlusion in one carotid artery, and
these patients were referred directly from the
clinic. One angiogram identified more extensive
stenosis than was found on the Doppler
ultrasound. This patient had recurrent
transient ischemic attacks (TIAs) after medical
clinic review commenced, and was found to
have 50–60% carotid artery stenosis on Doppler
ultrasound. However, the angiogram
subsequently showed occlusion of 80%, and
the patient was then considered for carotid
endarterectomy. Therefore, one patient was
found to have significant carotid artery
stenosis through angiography rather than
Doppler ultrasound, meaning that nine
patients (23%) overall were found to have
significant carotid artery stenosis. All 44
patients received an echocardiogram, 43 of
which were normal. One showed findings not
considered relevant to embolic disease, but
further cardiac investigations were carried out.
One patient underwent carotid
endarterectomy (Table 2). This patient was
initially found to have asymptomatic carotid
stenosis and an asymptomatic retinal embolus.
After surgical assessment, endarterectomy was
discussed, but the patient declined intervention
Table 1 Baseline characteristics of cohort
Mean Standard deviation Range
Age (years) 71 7.8 50–89
Body mass index (kg/m2) 31.2 4.8 21–50
Glycated hemoglobin (mmol/mol) 55 13.0 31–95
Systolic blood pressure (mmHg) 148.3 24.4 76–236
Diastolic blood pressure (mmHg) 80.4 13.6 54–125
Total cholesterol (mmol/L) 4.2 0.81 2.9–5.7
Low density lipoprotein (mmol/L) 2.1 0.91 0.3–5.0
High-density lipoprotein (mmol/L) 1.2 0.34 0.6–1.9
Triglycerides (mmol/L) 2.3 0.84 1.0–4.4
Table 2 Carotid Doppler ultrasound results, with subsequent management
Carotid Doppler
ultrasound % of stenosis
<50% 50–69% 70–99% Complete occlusion Total
Number with level of stenosis 27/39 (69%) 4/39 (10%) 3/39 (8%) 5/39 (13%) 39
No change to management 13/27 (48%) 1/4 (25%) 0 0 14/39 (36%)
Medication change 14/27 (52%) 3/4 (75%) 3/3 (100%) 2/5 (40%) 22/39 (56%)
Maximal medical therapy 0 1/4 (25%) 2/3 (67%) 5/5 (100%) 8/39 (21%)
Considered for surgery 0 1/4 (25%) 3/3 (100%) 0 4/39 (10%)
Underwent carotid endarterectomy 0 0 1/3 (33%) 0 1/39 (3%)
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and was managed medically. Six months later,
however, he experienced a retinal TIA, was
re-referred, and underwent endarterectomy
9 days later.
The four patients considered for carotid
stenting or carotid endarterectomy all had
significant carotid artery stenosis without
complete occlusion. One patient underwent
carotid endarterectomy. Two patients declined
surgery, and another was unable to lie flat to
undergo angiography to further assess the
extent of carotid artery stenosis. Therefore,
these three patients received maximal medical
therapy. The five patients with complete
occlusion of one carotid artery also received
maximal medical therapy (Table 2).
In total, 56% of the group had one or more
changes made to medication (Table 2). The
most common medication change was the
addition of an antiplatelet agent, which
occurred in 7/39 (18%) patients (Table 3).
Twenty-one percent (8/39) received changes to
lipid-lowering medication, 12/39 (31%) had
changes to anti-hypertensive medication, and
6/39 (16%) had changes to diabetes medications
(Table 3). Seven individuals underwent 24-h
ambulatory blood pressure monitoring (24-h
ABPM), with four patients receiving changes to
anti-hypertensive medication as a result and
three patients having normal 24-h ABPM.
We also examined the number of individuals
with a history of stroke or TIA and the number
of individuals who suffered strokes or TIAs after
the detection of the retinal embolus. In total,
ten patients (26%) experienced a
cerebrovascular event either before or after
detection of the retinal embolus. Four patients
had a stroke or TIA between the time they were
first seen and the time they were discharged
from the clinic, and all were individuals who
were found to have significant stenosis before
having a stroke or TIA. The mean duration of
clinic follow-up was 8 months. No patients
suffered a stroke or TIA between discharge and
case note review.
DISCUSSION
Referral Pathway
The results of our study suggest that a targeted
medical evaluation and optimization of
cerebrovascular risk factors should be carried
out in individuals with asymptomatic retinal
emboli found on retinal screening. Unlike
several other reported pathways [3–5], our
pathway leads to physician referral from
retinal screening, which avoids delay in
implementing any necessary medical or
Table 3 Percentages of patients with changes to medication by type of medication
Anti-platelet Lipid lowering Anti-hypertensive Diabetes
Dose change 0/39 (0%) 2/39 (5%) 2/39 (5%) 1/39 (3%)
Drug change 0/39 (0%) 3/39 (8%) 5/39 (13%) 5/39 (13%)
Newly added 7/39 (18%) 3/39 (8%) 4/39 (10%) 0/39 (0%)
Proportion with a medication change
with raised parameter
Not applicable 7/24 (30%) 4/16 (25%) 6/11 (57%)
Total proportion with a medication change 7/39 (18%) 8/39 (21%) 11/39 (28%) 6/39 (16%)
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surgical management for these patients. Hadley
et al. reported that detection of retinal emboli
through retinal screening led to a direct referral
for carotid Doppler ultrasound and subsequent
multidisciplinary review with
ophthalmologists, radiologists and vascular
surgeons to consider surgical options [5]. This
approach does result in individuals receiving
surgery that they may not otherwise have had.
Referral of individuals with asymptomatic
retinal emboli to ophthalmology departments
also may not be useful [4]. Neither of these
approaches directly addresses the potential
need to improve a patient’s medical
management. Ahmed et al. [3] described a
pathway whereby individuals found to have
asymptomatic retinal emboli at retinal
screening were referred back to their primary
care physicians, which did lead to changes in
medical therapy, and a similar proportion of
patients underwent carotid endarterectomy, but
there was no standard protocol for investigation
or management once the individual had been
referred to primary care [3]. In contrast, our
pathway offers a standardized approach to the
investigation and management of this patient
group.
Incidence and Prevalence of Retinal
Emboli
The incidence of retinal emboli among our
patient cohort was 0.32% over a period of
15 months. Other studies have reported a
cumulative incidence of 1.5–2.9% over
10 years [8, 9], which is similar to our finding.
In the first year of the screening program, the
prevalence of retinal emboli in the local area
was 1.5% (personal communication with DHW
Steel). The prevalence of retinal emboli has
been examined in several groups, and ranged
from 0.4% to 1.9% [2, 3, 5, 10–12]. However an
important characteristic of this cohort is that all
patients had diabetes, which was shown to
affect the prevalence of retinal emboli in a
large population study [2]. Retinal emboli were
reported at a prevalence of 0.85% [5] and 1.9%
[3] in two studies based on retinal screening
populations, which is also broadly similar to our
prevalence for the local area.
Twenty-nine percent of the cohort was either
a current or ex-smoker (Table 1). Because
smoking has been associated with an increased
incidence of retinal emboli [11, 12], smoking
cessation services should be included in clinical
pathways. Thirty-eight percent of our patients
had experienced myocardial infarction or
ischemic heart disease, both of which have
also been associated with an increased
prevalence of retinal emboli [13].
Utility of Investigations
The proportion of the cohort found to have
significant carotid artery stenosis on carotid
Doppler ultrasound was broadly similar to that
in other studies, which reported an incidence of
12.5% [5] and 22% [3]. The lower incidence
found by Hadley et al. [5] could reflect the larger
number of patients in the study. Carotid artery
stenosis of 70% or greater is considered
significant, and carotid endarterectomy is
reported to be of benefit in reducing the risk
of stroke if the patient is symptomatic and the
carotid artery is not fully occluded [14]. Carotid
endarterectomy in patients with one fully
occluded carotid artery was shown to provide
no benefit over maximal medical therapy in two
randomized controlled trials [14–16]. For
patients with non-significant stenosis and a
recent history of TIA or stroke, maximal
medical therapy is recommended, given the
risk of further stroke caused by surgery [14–16].
In the Asymptomatic Carotid Surgery Trial,
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carotid endarterectomy was shown to reduce
the risk of stroke in asymptomatic individuals
under the age of 75 with significant carotid
artery stenosis [17].
Cardiac sources of retinal emboli are usually
calcified valves or rheumatic heart disease
[18, 19]. In our study group, we found no
abnormalities on echocardiography that could
be considered a potential source for retinal
emboli. Other studies have not used
echocardiography in all patients [3–5]. In one
study, valvular disease—which could act as a
source—was found on echocardiography in
about 9% of patients with retinal emboli [3].
Our study suggests that echocardiography may
not be required in all patients with retinal
emboli. However, the best method for selecting
patients to receive echocardiography is not clear.
The existing literature suggests that
angiography has not been used extensively for
investigation of individuals with retinal emboli.
Confirmation of stenosis findings using
angiograms may be warranted for patients
with 60% stenosis or more on Doppler
ultrasound, in order to prevent individuals
with significant stenosis from being missed
and therefore not being considered for further
surgical intervention. Similarly, angiography
may be useful for confirmation of total
occlusion.
There are several limitations to this study.
The number of patients studied was small, and
the period during which patients with incident
retinal emboli were identified was short.
Therefore, the management of relatively few
patients forms the basis of recommendations
presented here. The follow-up time for all
patients after discharge was brief, and other
cerebrovascular events after discharge might
have been identified if follow-up periods had
been longer and had been the same length of
time for all individuals.
CONCLUSIONS
Here we propose a pathway for the investigation
and management of individuals with diabetes
found to have retinal emboli on annual retinal
screening. This pathway enables the
identification of individuals eligible for surgical
intervention before a cerebrovascular event
occurs. It is important that individuals with
asymptomatic retinal emboli are reviewed by a
physician to improve medical management of
cardiovascular risk factors. In addition, Doppler
ultrasound should be performed for every patient,
because significant carotid artery stenosis could
be found, and may be amenable to surgical or
medical management. Echocardiography did not
show obvious sources of retinal emboli,
suggesting that this investigation may not
always be necessary. Larger studies with
long-term follow-up are needed to further assess
the utility of the proposed pathway.
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